These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4147573)

  • 21. The neurochemistry of Parkinson's disease: effect of L-dopa therapy.
    Lloyd KG; Davidson L; Hornykiewicz O
    J Pharmacol Exp Ther; 1975 Dec; 195(3):453-64. PubMed ID: 489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Genetics of Parkinson's disease].
    García de Yébenes J
    Neurologia; 2001 Jan; 16(1):1-6. PubMed ID: 11234656
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression of 8-oxoguanine DNA glycosylase (OGG1) in Parkinson's disease and related neurodegenerative disorders.
    Fukae J; Takanashi M; Kubo S; Nishioka K; Nakabeppu Y; Mori H; Mizuno Y; Hattori N
    Acta Neuropathol; 2005 Mar; 109(3):256-62. PubMed ID: 15841414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication.
    Orimo S; Uchihara T; Nakamura A; Mori F; Ikeuchi T; Onodera O; Nishizawa M; Ishikawa A; Kakita A; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2008 Nov; 116(5):575-7. PubMed ID: 18751989
    [No Abstract]   [Full Text] [Related]  

  • 25. Unraveling the role of defective genes in Parkinson's disease.
    Dawson TM
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S248-9. PubMed ID: 18267244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    Mov Disord; 1994 May; 9(3):337-9. PubMed ID: 7913740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease. Genetic analysis and evidence of a multifactorial etiology.
    Kondo K; Kurland LT; Schull WJ
    Mayo Clin Proc; 1973 Jul; 48(7):465-75. PubMed ID: 4716218
    [No Abstract]   [Full Text] [Related]  

  • 28. LRRK2: a link between familial and sporadic Parkinson's disease?
    Lesage S; Dürr A; Brice A
    Pathol Biol (Paris); 2007 Mar; 55(2):107-10. PubMed ID: 16884863
    [No Abstract]   [Full Text] [Related]  

  • 29. [Abnormalities of catecholamine metabolism in Parkinson's disease (author's transl)].
    Nagatsu T
    Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1781-8. PubMed ID: 6117927
    [No Abstract]   [Full Text] [Related]  

  • 30. Extreme anticipation in young-onset Parkinson's disease.
    Djaldetti R; Ziv I; Melamed E
    Mov Disord; 1998 May; 13(3):599-600. PubMed ID: 9613762
    [No Abstract]   [Full Text] [Related]  

  • 31. [Genetics of extrapyramidal diseases].
    Brice A
    Rev Neurol (Paris); 1998 Nov; 154(11):739-42. PubMed ID: 9894286
    [No Abstract]   [Full Text] [Related]  

  • 32. MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese.
    Lee CG; Tang K; Cheung YB; Wong LP; Tan C; Shen H; Zhao Y; Pavanni R; Lee EJ; Wong MC; Chong SS; Tan EK
    J Med Genet; 2004 May; 41(5):e60. PubMed ID: 15121788
    [No Abstract]   [Full Text] [Related]  

  • 33. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial aggregation of Parkinson's disease in a Finnish population.
    Autere JM; Moilanen JS; Myllylä VV; Majamaa K
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):107-9. PubMed ID: 10864614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The G2019S LRRK2 mutation is uncommon amongst Greek patients with sporadic Parkinson's disease.
    Kalinderi K; Fidani L; Bostantjopoulou S; Katsarou Z; Kotsis A
    Eur J Neurol; 2007 Oct; 14(10):1088-90. PubMed ID: 17880562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson's disease: from brain homogenate to treatment.
    Hornykiewicz O
    Fed Proc; 1973 Feb; 32(2):183-90. PubMed ID: 4143953
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component.
    Perez-Pastene C; Graumann R; Díaz-Grez F; Miranda M; Venegas P; Godoy OT; Layson L; Villagra R; Matamala JM; Herrera L; Segura-Aguilar J
    Neurosci Lett; 2007 May; 418(2):181-5. PubMed ID: 17403576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New dopaminergic neurons in Parkinson's disease striatum.
    Porritt MJ; Batchelor PE; Hughes AJ; Kalnins R; Donnan GA; Howells DW
    Lancet; 2000 Jul; 356(9223):44-5. PubMed ID: 10892768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an enzyme-linked immunosorbent assay (ELISA) to measure the level of tyrosine hydroxylase protein in brain tissue from Parkinson's disease models.
    Fauss D; Motter R; Dofiles L; Rodrigues MA; You M; Diep L; Yang Y; Seto P; Tanaka K; Baker J; Bergeron M
    J Neurosci Methods; 2013 May; 215(2):245-57. PubMed ID: 23537934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.